RUNX2 and nonpapillary renal cell carcinoma: IHC staining analyses with antibodies against Zic2, Runx2, and NOLC1 in ccRCC tissue microarray were respectively performed to synthetically evaluate the survival of ccRCC patients based on the expression level of Zic2/Runx2/NOLC1 axis.